DSM-5: Diagnosis Trouble
Contributor: Gerald ClarkePosted: 5/20/2013
|
The controversy surrounding the impending release of the DSM-5 may have spurred on one of the most interesting developments in psychiatric medicine in decades. Our editor investigates the controversy and asks what's next for the world's most influential diagnostic manual. Full Article » |
President of ISBER: Looking to the Future of Biospecimen Science
Contributor: Kathi SheaPosted: 4/11/2013
 |
Kathi Shea, President at ISBER 2012-2013, discusses the goals for ISBER in 2013 Full Video » |
Lundbeck's Ludovic Otterbein on Bottlenecks and Best Practices in Compound Management
Contributor: Andrea CharlesPosted: 3/13/2013
 |
"Every company has compound collections of different sizes, but we all face the same challenge of the rising cost of R&D," said Ludovic Otterbein, Head of Global Compound Management and Analytical Chemistry at at H. Lundbeck A/S. Full Podcast » |
Copy More! Copy Better!
Contributor: Jonas BoströmPosted: 5/7/2013
 |
In his latest column, Jonas explains the pharma industry should re-examine its aversion to copying and how this aversion can restrict innovation. He then makes the case that 'follow-on' drugs are good for companies and patients. Full Column » |
Pharma Industry Report: A Global Guide to Clinically Relevant Drug Transporters
Posted: 5/24/2013 |
In this 10 page resource pack we look at drug transporter outsourcing, intelligent drug development applied to clinically relevant drug transporters and drug transporters in ADME. Plus feature interviews with leading experts from AstraZeneca, GlaxoSmithKline and The University of Oxford. Full Whitepaper » |
-
Taking EDC to the next level: Moving from point solutions to an eClinical ecosystem
April 4, 2013
Register Now -
Site Quality Management and Risk-Based Monitoring: A New Approach
December 4, 2012
Register Now -
Clinical Contract Development and Trial Oversight - Online Training Course
October 28, 2011
Register Now -
Electronic Laboratory Notebooks Online
December 2, 2011
Register Now
|
what is the definition of pharma area sales manager |
Posted by: prashantshrivastava | Answer this question
|
|
The USP published new drafts to revise the General Chapters 41 “Balances” and 1251 “Weighing on an Analytical Balance” in the... |
Posted by: aholder | Answer this question
|
|
Is it possible with a MEG (Magnetoencephalography) to measure the neural activitu or the VLPO (neuron firings)? |
Posted by: Insomnia | Answer this question
|
|
what is the requirement of chewable tablet bioequivalance study for brazil and what are the general |
Posted by: ramesh89pharma | Answer this question
|
|
what is the requirement of chewable tablet bioequivalance study for brazil and what are the general |
Posted by: ramesh89pharma | Answer this question
|
Reach Pharma professionals through cost-effective marketing opportunities to deliver your message, position yourself as a thought leader, and introduce new products, techniques and strategies to the market.
Learn More >> Learn how to sponsor a webinar with us? Join today and interact with a vibrant network of pharma professionals, keeping up to date with the pharma industry by accessing our wealth of Pharma articles, videos, online seminars, live conferences and more. Sign Up Today! |
| Pharma IQ, a division of IQPC 2013 All rights reserved. Use of this site constitutes acceptance of our User Agreement and Privacy Policy. Careers With IQPC | Contact Us | Unsubscribe to Bizo | About Us | Cookie Policy |
|
Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!